Tamera J. Corte

3.4k total citations
69 papers, 1.6k citations indexed

About

Tamera J. Corte is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Speech and Hearing. According to data from OpenAlex, Tamera J. Corte has authored 69 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Pulmonary and Respiratory Medicine, 20 papers in Physiology and 6 papers in Speech and Hearing. Recurrent topics in Tamera J. Corte's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (59 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Sarcoidosis and Beryllium Toxicity Research (16 papers). Tamera J. Corte is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (59 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Sarcoidosis and Beryllium Toxicity Research (16 papers). Tamera J. Corte collaborates with scholars based in Australia, United Kingdom and United States. Tamera J. Corte's co-authors include Ian Glaspole, Athol U. Wells, E. Haydn Walters, Yuben Moodley, Nicole Goh, Samantha Ellis, Paul N. Reynolds, Annabelle Mahar, Helen E. Jo and Lauren Troy and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Annals of the Rheumatic Diseases.

In The Last Decade

Tamera J. Corte

60 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tamera J. Corte Australia	26	1.5k	519	154	122	117	69	1.6k
Matteo Buccioli Italy	10	1.4k 1.0×	596 1.1×	110 0.7×	113 0.9×	106 0.9×	21	1.5k
Charlene D. Fell Canada	17	1.1k 0.7×	389 0.7×	135 0.9×	121 1.0×	96 0.8×	38	1.2k
Joseph M. Parker United States	17	718 0.5×	605 1.2×	121 0.8×	79 0.6×	73 0.6×	41	1.2k
Shane Shapera Canada	16	754 0.5×	293 0.6×	80 0.5×	57 0.5×	79 0.7×	54	915
Ayodeji Adegunsoye United States	28	1.8k 1.2×	718 1.4×	222 1.4×	186 1.5×	351 3.0×	102	2.1k
Charlotte Hyldgaard Denmark	15	828 0.6×	417 0.8×	65 0.4×	221 1.8×	192 1.6×	41	962
Bridget F. Collins United States	12	525 0.4×	237 0.5×	37 0.2×	126 1.0×	165 1.4×	27	703
Carla G. Wilson United States	15	1.0k 0.7×	355 0.7×	58 0.4×	31 0.3×	52 0.4×	30	1.3k
Marios Rossides Sweden	13	272 0.2×	289 0.6×	64 0.4×	104 0.9×	83 0.7×	34	576
Jan Parner Denmark	10	864 0.6×	839 1.6×	87 0.6×	12 0.1×	103 0.9×	14	1.4k

Countries citing papers authored by Tamera J. Corte

Since Specialization

Citations

This map shows the geographic impact of Tamera J. Corte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamera J. Corte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamera J. Corte more than expected).

Fields of papers citing papers by Tamera J. Corte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamera J. Corte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamera J. Corte. The network helps show where Tamera J. Corte may publish in the future.

Co-authorship network of co-authors of Tamera J. Corte

This figure shows the co-authorship network connecting the top 25 collaborators of Tamera J. Corte. A scholar is included among the top collaborators of Tamera J. Corte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamera J. Corte. Tamera J. Corte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Nan, Francesco Federico, Stephen M. Humphries, et al.. (2025). Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. European Respiratory Journal. 66(4). 2500981–2500981.

Tikellis, Gabriella, Tamera J. Corte, Ryan Hoy, et al.. (2025). Developing a Model of Health and Supportive Care for People with Silicosis in Australia. Annals of the American Thoracic Society. 23(1). 63–69.

Tan, Dino B.A., Wendy A. Cooper, Helen E. Jo, et al.. (2025). Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients. Respirology. 30(6). 504–514. 2 indexed citations

Corte, Tamera J., Deepthi Nair, Hao Bao, et al.. (2025). Long-term Safety and Efficacy Data With Inhaled Pirfenidone (AP01) in the Atlas Open-label Extension Study Up to 240 Weeks. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2906–A2906.

Holland, Anne E., Mariana Hoffman, Tamera J. Corte, et al.. (2025). Ambulatory Oxygen for Treatment of Exertional Hypoxaemia in Pulmonary Fibrosis (PFOX Trial): A Randomised Sham-Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A2907–A2907.

Glenn, Laura, Dan Jackson, Karen Symons, et al.. (2024). Usability of a smartphone application for patients with interstitial lung disease: Results from the Registry for Better Understanding of ILD (RE‐BUILD) pilot study. Respirology. 30(2). 147–157. 1 indexed citations

Mackintosh, John A., Gregory J. Keir, Lauren Troy, et al.. (2024). Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology. 29(2). 105–135. 26 indexed citations

Spencer, Lissa, Jennifer Alison, Susanne Webster, et al.. (2024). The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respiratory Medicine. 232. 107748–107748. 2 indexed citations

Yang, Nan, Guang‐Zhong Yang, John A. Mackintosh, et al.. (2023). Deep Learning-Based Quantification of Traction Bronchiectasis Severity For Predicting Outcome in Idiopathic Pulmonary Fibrosis. 76–78.

10.

Tikellis, Gabriella, Tamera J. Corte, Alan Teoh, et al.. (2021). Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. Respirology. 27(1). 76–84. 10 indexed citations

11.

Dowman, Leona, Anthony K. May, Catherine J. Hill, et al.. (2021). High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial. BMC Pulmonary Medicine. 21(1). 361–361. 6 indexed citations

12.

Cooper, Wendy A., Annabelle Mahar, Jeffrey L. Myers, et al.. (2020). Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features. Further Lessons from COLDICE, a Prospective Multicenter Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 203(10). 1306–1313. 30 indexed citations

13.

Holland, Anne E., Tamera J. Corte, Daniel C. Chambers, et al.. (2020). Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX trial): a randomised controlled trial. BMJ Open. 10(12). e040798–e040798. 12 indexed citations

14.

McLean, Anna, Susanne Webster, Margaret Fry, et al.. (2020). Priorities and expectations of patients attending a multidisciplinary interstitial lung disease clinic. Respirology. 26(1). 80–86. 11 indexed citations

15.

Lee, Joanna Y.T., Gabriella Tikellis, Tamera J. Corte, et al.. (2020). The supportive care needs of people living with pulmonary fibrosis and their caregivers: a systematic review. European Respiratory Review. 29(156). 190125–190125. 54 indexed citations

16.

Lau, Edmund, Christopher Grainge, Jonathan Williamson, et al.. (2020). Methodologies of COLDICE and Cryo-PID studies: details make the difference. Annals of Translational Medicine. 8(12). 781–781. 1 indexed citations

17.

Culver, Daniel A., Jürgen Behr, John A. Belperio, et al.. (2019). Patient Registries in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 200(2). 160–167. 26 indexed citations

18.

Troy, Lauren, Iven H Young, Edmund Lau, et al.. (2019). Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease. Respirology. 24(10). 996–1004. 40 indexed citations

19.

Jee, Adelle S., Tamera J. Corte, Stephen J. Wort, et al.. (2017). Year in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep. Respirology. 22(5). 1022–1034. 1 indexed citations

20.

Wilcox, Pearce, Ian Glaspole, Tamera J. Corte, et al.. (2017). Cough is less common and less severe in systemic sclerosis‐associated interstitial lung disease compared to other fibrotic interstitial lung diseases. Respirology. 22(8). 1592–1597. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact